FGAM
PLRX icon

Financial Gravity Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Financial Gravity Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19
Closed -$290 – 2161
2024
Q1 		$290 Buy
+19
New +$313 ﹤0.01% 1539
2023
Q3 		– Sell
-18
Closed -$194 – 1627
2023
Q2 		$194 Buy
+18
New +$426 ﹤0.01% 1183
2023
Q1 		– Sell
-19
Closed -$218 – 1515
2022
Q4 		$218 Buy
+19
New +$397 ﹤0.01% 925

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Financial Gravity Asset Management's PLRX Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Pliant Therapeutics (PLRX) in Q2 2024, closing a stake of 19 shares — an estimated $290 sold.

Financial Gravity Asset Management first reported a position in PLRX in Q4 2022 and held it in 3 quarters. The position peaked at $290 in Q1 2024. 143 funds tracked by Wall St. Rank hold PLRX as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining Pliant Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 19 Pliant Therapeutics shares in Q2 2024, an estimated $290.
  • Financial Gravity Asset Management first reported a position in Pliant Therapeutics in Q4 2022 and held it in 3 quarters.
  • Financial Gravity Asset Management's Pliant Therapeutics position peaked at $290 in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.